ANNX Annexon Inc

Price (delayed)

$3.85

Market cap

$148.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.64

Enterprise value

$68.65M

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
Annexon's EPS has surged by 88% YoY but it has decreased by 7% QoQ
Annexon's quick ratio has plunged by 60% YoY but it has increased by 9% from the previous quarter
The company's net income has shrunk by 81% YoY and by 7% QoQ
The equity has declined by 38% year-on-year and by 13% since the previous quarter

Key stats

What are the main financial stats of ANNX
Market
Shares outstanding
38.56M
Market cap
$148.47M
Enterprise value
$68.65M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$139.64M
EBITDA
-$136.01M
Free cash flow
-$119.82M
Per share
EPS
-$3.64
Free cash flow per share
-$3.11
Book value per share
$5.2
Revenue per share
$0
TBVPS
$6.5
Balance sheet
Total assets
$250.57M
Total liabilities
$49.96M
Debt
$34.18M
Equity
$200.61M
Working capital
$194.2M
Liquidity
Debt to equity
0.17
Current ratio
12.39
Quick ratio
12.19
Net debt/EBITDA
0.59
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-47.4%
Return on equity
-56.3%
Return on invested capital
-63%
Return on capital employed
-59.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANNX stock price

How has the Annexon stock price performed over time
Intraday
-1.53%
1 week
28.33%
1 month
20.31%
1 year
-83.72%
YTD
-66.49%
QTD
41.03%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$139.94M
Net income
-$139.64M
Gross margin
N/A
Net margin
N/A
The company's operating income has shrunk by 81% YoY and by 7% QoQ
The company's net income has shrunk by 81% YoY and by 7% QoQ

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
0.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has surged by 88% YoY but it has decreased by 7% QoQ
The P/B is 63% lower than the last 4 quarters average of 2.0
The equity has declined by 38% year-on-year and by 13% since the previous quarter

Efficiency

How efficient is Annexon business performance
ANNX's ROA has shrunk by 69% YoY and by 15% QoQ
The return on invested capital has surged by 63% year-on-year but it has declined by 2.4% since the previous quarter
The ROE has dropped by 53% year-on-year and by 20% since the previous quarter

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's current ratio has plunged by 60% YoY but it has increased by 9% from the previous quarter
Annexon's quick ratio has plunged by 60% YoY but it has increased by 9% from the previous quarter
Annexon's debt is 83% less than its equity
The equity has declined by 38% year-on-year and by 13% since the previous quarter
The debt to equity has grown by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.